Oral Analgesia vs Intravenous Conscious Sedation during Essure Micro-Insert Sterilization Procedure: Randomized, Double-Blind, Controlled Trial

Thiel, John; Lukwinski, A.; Kamencic, Huse; Lim, Hyung Ho

doi:10.1016/j.jmig.2010.10.006

Cited by 41 publications

(12 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…One area of concentration in this literature is procedure-related, such as finding higher successful placement rates in the outpatient versus inpatient setting [22,26]. Some researchers demonstrate an association between placement failure and an increased length of procedure, [2,34], but placement rates have not been significantly associated with time in the recovery area, performing a concomitant intrauterine surgical procedure [23,28], or provider experience [8,34]. Further, no association has been observed between placement rates and certain types of anesthesia or premedication [18,23,28,34] with the exception of decreased failure rates when anti-inflammatory agents are used to reduce tubal spasm [7,8,22].…”

Section: Introductionmentioning

confidence: 99%

“…Another study observed a relationship between failure rates and body mass index (BMI) [27] while others have observed a positive relationship between failure rates most likely due to visualization and certain phases of the menstrual cycle [23,25,27]. Placement rates do not appear to be significantly associated with age, race, parity, gravidity, pain experience, tobacco or illicit drug use, history of ectopic pregnancy, history of cesarean section, or hormonal contraceptive usage [8, 12,15,18,22,23,26,28,34]. …”

Section: Introductionmentioning

confidence: 99%

“…Furthermore, few data are available on placement rates among women at risk for tubal disease as they are often excluded from the studies. In addition, few data are available on placement rates using the new ESS305 design, third-generation model which was approved for use in the US in June 2007 [24,28,32,36]. The current study adds to the literature by examining risk markers associated with the inability to deploy the Essure® coils into the tubal lumen using the new ESS305 design, third-generation model.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Tubal risk markers for failure to place transcervical sterilization coils

et al. 2012

View full text Add to dashboard Cite

Background There is a growing body of literature on placement rates of the Essure® procedure, yet prior studies have not attempted to identify tubal-associated risk factors for placement failures. The current study examines risk markers associated with the inability to deploy the Essure® coils into the tubal lumen using the new ESS305 design. Study Design We used electronic medical record data to assess risk markers associated with the inability to place the Essure coils in the tubal lumen using the new ESS305 design. A total of 310 attempted procedures between June 14, 2007, and April 29, 2011 were analyzed. Results There were 18 tubal failures (5.8%) out of the 310 attempted procedures. A history of a prior sexually transmitted infection (STI) was associated with tubal failure (OR 2.64, 95% confidence interval (CI) 1.01–6.90; p=.048). Conclusions We speculate that the observed association between a prior STI and an inability to place the coil was due to a past history of pelvic inflammatory disease.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Tubal risk markers for failure to place transcervical sterilization coils

et al. 2012

View full text Add to dashboard Cite

show abstract

“…Regarding the analgesia used in the placement of the Essure, there is a variety of studies that evaluate the pain during the procedure, and different analgesia protocols were used in them. Thiel et al 19 compared intravenous sedation with oral analgesia, and concluded that they are equivalent.…”

Section: Discussionmentioning

confidence: 99%

Definitive Contraception: Trends in a Ten-year Interval

Marques

Magalhães

Carvalho

et al. 2017

Rev Bras Ginecol Obstet

View full text Add to dashboard Cite

Objective To evaluate the trends in definitive contraception in a ten-year interval comprising the years 2002 and 2012. Method Retrospective analysis of the tubal sterilization performed in our service in 2002 and 2012, analyzing the demographic characteristics, personal history, previous contraceptive method, definite contraception technique, effectiveness and complications. Results Definitive contraception was performed in 112 women in 2002 (group 1) and in 60 women in 2012 (group 2). The groups were homogeneous regarding age, parity, educational level and personal history. The number of women older than 40 years choosing a definitive method was more frequent in group 1, 49.1% (n ¼ 55); for group 2, the rate was 34.8% (n ¼ 23) (p ¼ 0.04). The time between the last delivery and the procedure was 11.6 AE 6.2 and 7.9 AE 6.4 years (p ¼ 0.014) in 2002 against 2012 respectively. In 2002, all patients performed tubal ligation by laparoscopic inpatient regime. In 2012, the bilateral placement of the Essure (Bayer Corporation, Whippany, NJ, US) device was suggested to 56.1% (n ¼ 37) of the patients, while laparoscopy was suggested to 43.9% (n ¼ 29) of them. All women who underwent laparoscopic sterilization had the procedure successfully completed using silastic rings. The overall bilateral device placement rate for the Essure was 91.6%, with only one complication reported. All Essure procedures were performed in an outpatient setting; for the laparoscopy, this rate was 79% (n ¼ 15). No intentional pregnancies occurred until this date. Conclusions There is a trend in the decrease in definitive contraception over the years in our institution, maybe as a result of the development of long-acting reversible contraceptives. The hysteroscopic procedure has become a frequent option, as it is performed in an office setting without anesthesia, being a well-tolerated, minimal invasive method.

show abstract

“…Dans une étude multicentrique française, nous avions montré une évolution des pratiques au cours des deux ans et demi de l'étude, avec un abandon progressif du bloc paracervical, une réduction significative de la sédation intraveineuse qui concernait 50 % des patientes en début d'étude et moins de 20 % en fin d'étude, alors que les patientes n'ayant qu'une prémédication orale passaient de moins de 20 % à près de 70 % en fin d'étude [7]. Ce point a d'ailleurs été confirmé par une étude randomisée en double aveugle publiée par Thiel et al en 2011 [8]. Cette étude montrait une bonne efficacité des deux méthodes avec une équivalence pour presque tout les temps de l'intervention sauf celui de l'insertion de l'hystéroscope et du placement du deuxième implant pour lesquels la sédation IV paraissait légèrement supérieure à l'efficacité de l'analgésie orale.…”

Section: Analgésieunclassified